Legal Representation
Attorney
Stacy L. Emhoff
USPTO Deadlines
Next Deadline
1445 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-07-18)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 18, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 18, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Oct 18, 2023 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| Oct 18, 2023 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Jul 31, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jul 18, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 18, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 12, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jul 12, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| May 2, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 2, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 1, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Apr 12, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 12, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Apr 12, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 30, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 30, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 30, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 30, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 4, 2023 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
| Dec 9, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Dec 8, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 28, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 15, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 10, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; Pharmaceutical preparations for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemico-pharmaceutical preparations for pharmaceutical purposes, namely, chemico-pharmaceutical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemico-pharmaceutical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Medicated serums used for the functional analysis of blood coagulation and fibrinolysis; Medicated serums used for the quantitative and qualitative detection of analytes in human serum, plasma and body fluids; Medicines for serum therapy, namely, medicines for serum therapy for functional analysis of blood coagulation and fibrinolysis; Medicines for serum therapy for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Biological preparations for medical purposes, namely, biological preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; Biological preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemical preparations for pharmaceutical purposes, namely, chemical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; chemical preparations for medical purposes, namely, chemical preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; chemical preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; enzymes for medical purposes; enzyme preparations for medical purposes; Preparations for pharmaceutical purposes, namely, preparations for pharmaceutical purposes made of trace elements that are found in the human body for the functional analysis of blood coagulation and fibrinolysis; Preparations for pharmaceutical purposes made of trace elements that are found in the human body for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; amino acids for medical purposes; preparations of microorganisms for medical or veterinary use; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; veterinary preparations for treatment of intestinal bacteria; medicines for veterinary purposes for treatment of intestinal bacteria; biological preparations for veterinary purposes for treatment of intestinal bacteria; chemical preparations for veterinary purposes for treatment of intestinal bacteria; enzymes for veterinary purposes; enzyme preparations for veterinary purposes; diagnostic preparations for veterinary purposes; reagent paper for veterinary purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005